These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 177190)

  • 41. Comparison of adriamycin (NSC-123127) and the combination of 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in advanced prostatic cancer: a preliminary report.
    Eagan RT; Utz DC; Myers RP; Furlow WL
    Cancer Chemother Rep; 1975; 59(1):203-7. PubMed ID: 1093666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Futraful therapy on liver cancer.
    Kurihara M; Shirakabe H; Izumi T; Miyasaka K; Ariyama J
    Clin Oncol; 1977 Mar; 3(1):33-49. PubMed ID: 193664
    [No Abstract]   [Full Text] [Related]  

  • 43. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
    Levitt SH; Potish RA
    Cancer Clin Trials; 1981; 4(4):363-9. PubMed ID: 7032731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A combination therapy with copper nicotinate complex reduces the adverse effects of 5-fluorouracil on patients with hepatocellular carcinoma.
    El-Saadani MA
    J Exp Ther Oncol; 2004 Apr; 4(1):19-24. PubMed ID: 15255289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary trials with a combination of adriamycin (NSC-123127) and bleomycin (NSC-125066) in adult malignancies.
    Tormey DC; Bergevin P; Blom J; Petty W
    Cancer Chemother Rep; 1973; 57(4):413-8. PubMed ID: 4128422
    [No Abstract]   [Full Text] [Related]  

  • 46. Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I study.
    Tranum BL; Stephens RL; Lehane DE; Hoogstraten B; Lane M; Haut A
    Cancer Chemother Rep; 1975; 59(6):1163-5. PubMed ID: 769959
    [No Abstract]   [Full Text] [Related]  

  • 47. [Autopsy case of liver cancer undetected until the terminal stage].
    Hattori M; Katsuta K; Hozumi M
    Iryo; 1970 Mar; 24(3):249-55. PubMed ID: 4316183
    [No Abstract]   [Full Text] [Related]  

  • 48. Intra-arterial chemotherapy in the treatment of primary liver cancer.
    Lange M; Falkson G; Geddes E
    S Afr J Surg; 1974 Dec; 12(4):245-9. PubMed ID: 4614473
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
    Muss HB; White DR; Cooper MR; Richards F; Spurr CL
    Arch Intern Med; 1977 Dec; 137(12):1711-4. PubMed ID: 337916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy.
    Ferrari D; Di Maria G; Fazio N; Codecà C; Fiore J; Luciani A; Oldani S; Maggioni M; Foa P
    Anticancer Drugs; 2008 Sep; 19(8):837-40. PubMed ID: 18690097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination cancer chemotherapy--a clinical trial on outpatients.
    Ti TK; Yong NK
    Med J Malaysia; 1974 Mar; 28(3):165-70. PubMed ID: 4278036
    [No Abstract]   [Full Text] [Related]  

  • 53. Prolonged survival with hepatocellular carcinoma.
    Penalba C; Larouze B; Mechali D; Saimot G; Coulaud JP
    Gastroenterology; 1982 Nov; 83(5):1159. PubMed ID: 6288508
    [No Abstract]   [Full Text] [Related]  

  • 54. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
    Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
    [No Abstract]   [Full Text] [Related]  

  • 55. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA; Grillo-López A; Vélez-Garciá E
    Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
    [No Abstract]   [Full Text] [Related]  

  • 56. [Preliminary results of a continuous study protocol with adjuvant chemotherapy in primary operable breast carcinoma].
    Cavalli F; Jungi F; Alberto P; Martz G; Brunner KW
    Haematol Blood Transfus; 1978; 22():61-6. PubMed ID: 374200
    [No Abstract]   [Full Text] [Related]  

  • 57. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M; Kobayashi Y; Urawa N; Yamamoto M; Mifuji R; Araki J; Tanaka H; Horiike S; Itani T; Furjita N; Konishi M; Iwasa M; Kaito M; Adachi Y
    Hepatogastroenterology; 2007 Mar; 54(74):518-21. PubMed ID: 17523311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis.
    Nagamatsu H; Hiraki M; Mizukami N; Yoshida H; Iwamoto H; Sumie S; Torimura T; Sata M
    Aliment Pharmacol Ther; 2010 Aug; 32(4):543-50. PubMed ID: 20500734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study.
    Lin CL; Chien RN; Yeh C; Hsu CW; Chang ML; Chen YC; Yeh CT
    Scand J Gastroenterol; 2014 Dec; 49(12):1456-64. PubMed ID: 25283499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral fluorouracil therapy of hepatoma.
    Kennedy PS; Lehane DE; Smith FE; Lane M
    Cancer; 1977 May; 39(5):1930-5. PubMed ID: 192440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.